Home » Comparative Effectiveness of Pomalidomide Plus Low-Dose Dexamethasone (POM+LoDEX) in Relapsed and Refractory Multiple Myeloma: Use of Real-World Data in the Absence of Head-to-Head Studies
Comparative Effectiveness of Pomalidomide Plus Low-Dose Dexamethasone (POM+LoDEX) in Relapsed and Refractory Multiple Myeloma: Use of Real-World Data in the Absence of Head-to-Head Studies - TriNetX
Comparative Effectiveness of Pomalidomide Plus Low-Dose Dexamethasone (POM+LoDEX) in Relapsed and Refractory Multiple Myeloma: Use of Real-World Data in the Absence of Head-to-Head Studies
